Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Cannabis Law Report

MAY 14, 2022

The process, which requires non-medicinal CBD products to be the subject of an application for authorisation has caused a stir within UK-CBD stocks and laid bare the industry’s reliance on white-label goods. Medicinal cannabis products have been available since 2018. That position could dramatically change.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

APRIL 12, 2019

A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication.

Access 45

Access Patients Marijuana Medicine 45

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 206

Retail Sleep History Medicine 206

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. Psychiatric disorders accounted for 11,914 patients.

Programs 72

Programs Patients Dispensary Cultivation 72

MMJ Recs

JUNE 15, 2022

The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. Unique Pain Medicine. With three offices in NYC, Brooklyn, and Long Island, Unique Pain Medicine is conveniently located and takes multiple insurance plans.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

APRIL 1, 2022

Aguilar has suggested that “cannabis must have similar authorization and use conditions” to those that operate in Spain with products such as morphine and has opened the door for, at one time, community pharmacies -and not just hospital ones- dispense cannabinoid-based products that the Medicines Agency may authorize.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Joint Blog

MAY 5, 2020

PatientsAccording to a new study, access to cannabis reduces pain patients’ perceived demand for opioids. For the study researchers from John Hopkins School of Medicine examined whether or not cannabis availability would hypothetically influence pain patients’ demand for prescription opioids.

Access 49

Access Consumption Marijuana Medicine 49

Cannabis Law Report

NOVEMBER 10, 2019

Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. QLD is also well serviced with a variety of access clinics, which would have contributed to this relative increase.

Access 45

Access Medicine Data Patients 45

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Veriheal

NOVEMBER 22, 2021

Have you ever wondered who spends more on cannabis: those who consume recreationally or for medicinal purposes? Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Well, we’ve got answers.

Recreational 98

Recreational Data Dispensary Cannabis 98

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. “You This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

Veriheal

AUGUST 15, 2022

Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. The sessions were logged by a total of 1,224 people who had access to the app. Promising News for Endless Patients. Consequently, more people could eventually gain access to cannabis-based medicines for fatigue.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

MAY 12, 2022

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. deserves access to effective?treatments.”

Sleep 52

Sleep Access Patients Treatment 52

Cannabis Law Report

JULY 24, 2019

Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field. Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . I use my prescription to treat my anxiety, ADHD+ and Autism.

Patients 52

Patients Conditions Treatment Education 52

MMJ Recs

AUGUST 30, 2021

In 2014, Governor Jay Nixon signed the Missouri Medical Marijuana Bill, making it possible for CBD to be used as medicine for seizures. This legalization has been good for both patients and for the government, which is profiting significantly from the changes in MMJ law. Is medical marijuana being sold in Missouri yet?

Seed-To-Sale 98

Seed-To-Sale Business Marijuana Dispensary 98